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Objectives: To examine the effects of oral glucose load on forearm circulatory regulation before and after
ascorbic acid administration in healthy subjects.
Design: Microcirculation study with laser Doppler was performed at the hand in basal conditions, after
ischemia and after acetylcholine and nitroprusside; strain gauge plethysmography was performed at basal
and after ischemia. The tests were repeated in the same sequence 2 hour after oral administration of glucose
(75 g). The subjects were randomised for administration of ascorbic acid (1 g bid) or placebo (sodium
bicarbonate 1 g bid) for 10 days. After that, the tests were repeated before and after a new oral glucose load.
Blood pressure and heart rate were monitored.
Results: Macrocirculatory ﬂux, pressure values and heart rate were unvaried throughout the study. The
glucose load caused a reduction in the hyperemic peak ﬂow with laser Doppler and plethysmography; it
reduced ﬂux recovery time and hyperemic curve area after ischemia; acetylcholine elicited a minor increase
in ﬂux with laser Doppler. The response to nitroprusside was unvaried after glucose load as compared to basal
conditions.
Treatment with ascorbic acid prevented the decrease in hyperemia after glucose, detected with laser Doppler
and plethysmography. Ascorbic acid prevented the decreased response to acetylcholine after glucose, the
response to nitroprusside was unaffected by ascorbic acid. Results after placebo were unvaried.
Conclusions: Oral glucose load impairs endothelium dependent dilation and hyperaemia at microcirculation,
probably via oxidative stress; ascorbic acid can prevent it.
© 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.1. Introduction
Several studies document the impairment of vasoregulation and in
particular of endothelial function in diabetic patients [1]. Endothelial
dysfunction indiabetes is attributed tomultiple factors and inparticular a
pivotal role is attributed to increased reactive oxygen species with
consequent nitric oxide (NO) degradation [2–4] and production of
peroxinitrite, which is a toxic molecule [5]. In fact, in hyperglycaemic
conditions an augmented production of reactive oxygen species has been
demonstrated to take place [6]. Some authors have observed that an oral
glucose load reduces endothelial dependent vasodilation in healthy
individuals at humeral artery [2,7,8] and in microcirculation [9].
Oxidative stress is evoked for such an impairment [6]. Furthermore
hyperglycaemia inducesmitogen activatedprotein kinase, protein kinase
C, transcription factor nuclear factor (NF)-κB that consequently activates
the expression of adhesion molecules [10]. Ascorbic acid is one of the
most efﬁcacious natural scavengers of reactive oxygen species and actsscolare, Università di Verona,
9 45 8126814; fax: +39 45
chi).
ration of Internal Medicine. Publishenhancing NO function [11]. Several authors have demonstrated that
ascorbic acid can recover endothelial dysfunction in different clinical
conditions such as ischemic heart disease [12], hyperomocisteinaemia
[13], hypertension [14] and smoking [15]. Other authors have demon-
strated that endothelial dysfunction, inducedby infusionofmannitol, can
be prevented by ascorbic acid infusion [16]. It has, furthermore, been
recently described how slight hyperinsulinaemia impairs endothelium
dependent vasodilation in large arteries; these data highlight the links
between hyperinsulinemia/insulin resistance and atherosclerosis [17]. It
is not still clear how endothelial vasoregulation in micro vessels and
reactive hyperaemia are affected during a physiological metabolic stress
such as an oral glucose load, which leads to a slight increase in glucose
and in insulin plasma levels; secondly howascorbic acidmodulates these
modiﬁcations. Further information can be obtained by studying the
ipoxic-reducing conditions determined by ischemia with the analysis of
the recovery phase during post ischemic hyperaemia.
2. Aim of the study
To evaluate the effects of an oral glucose load on macro- and
microcirculatory haemodynamic parameters in healthy subjects and if
ascorbic acid administration can modify these parameters.ed by Elsevier B.V. All rights reserved.
Table 1
Study population.
Baseline After treatment
AGE (years) 29–36 –
BMI 19±3 –
TOTAL CHOL. (mg/dl) 165±27 162±31
TRIGLYCERIDES (mg/dl) 136±12 133±15
HDL CHOL (mg/dl) 58±8 59±9
TOTAL CHOL./HDL (ratio) 5.4±1.1 5.3±1.3
GLUCOSE (mg/dl) 91±10 89±12
INSULIN (mU/l) 5.8±1.1 5.6±1.2
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3.1. Study population
Thirty-four healthy subjects, non smokers, aged 29–36 (17 females
and 17males). Lipid proﬁle (total cholesterol, HDL, LDL, triglycerides),
fasting blood glucose and glucose/insulin curves after oral glucose
load (75 g) were within range. They all had BMIb21 (Table 1).
The studywas carried out in our vascular laboratory at 9.00 a.m. in a
comfortable environment and at a constant temperature (22±1 °C).
After a 20-min period of stabilisation in supine position subjects
underwent microcirculatory evaluation with jontophoretic tests for
endothelium dependent and endothelium independent vasodilation on
the right hand. Tenminutes later a post ischemic testwas performed; on
the left armwe studied brachial ﬂowwith plethysmography at rest and
during reactive hyperaemia; blood pressure and heart rate monitoring
was performed during the tests. Afterwards subjects were asked to
drink a solution containing 75 g of glucose; 2 hours later the same
sequence of tests was performed. The subjects were randomised to
assume ascorbic acid (1 g bid) or placebo (sodium bicarbonate 1 g bid)
for 10 days, then the tests were repeated before and after oral glucose
load.
3.2. Haemodynamic measurements
The cutaneous microcirculatory system was studied by means of
laser Doppler (LD) (Periﬂux PF 3, Perimed, Stockolm, Sweden). This
device has a helio-neon laser that emits light at a wave-length of
632.8 nm, transmitted by optic ﬁbre to a probe. The device can measure
the dermal microcirculatory ﬂow through the analysis of the back-
scattered light and it expresses theﬂow inperfusion units (PU—arbitrary
units). With this method we can analyse dermal rest ﬂow (thermoreg-
ulatory and nutritive ﬂow), hyperﬂow after ischemia, endothelial-
dependent dilation (with acetylcholine administration)andendothelial-
independentdilation (with nitroprusside administration). LaserDoppler
probewas placed on the dorsum of the third ﬁnger of the right hand and
cutaneous microcirculatory ﬂux was evaluated at rest, after jontophore-
tic administration of acetylcholine (dose–response curve of 2% acetyl-
choline , 0.1 mA; doses administered for 10, 20, 40 s) and nitroprusside
(dose–response curve of 1% nitroprusside, 0.1 mA; doses administered
for 10, 20, 40 s) [18–20] and after 3 min ischemia induced with a cuff
placed 2 cm above the elbow and inﬂated 10 mm Hg over systolic
pressure. The reactive hyperaemiawas studied calculating the peak ﬂowTable 2
Blood pressure, heart rate, peripheral resistance (*pb0.005 vs rest and correspondent base
Baseline
Rest Glucose
Systolic pressure (mmHg) 119±4 109±6
Diastolic pressure (mmHg) 79±9 74±6
Heart rate (b/min) 74±3 71±8
Forearm resistance (mmHg/ ml/100 ml min−1) 34.1±2.1 39.3±1.5
Microcirculatory resistance (mm Hg/PU) 1.7±0.4 1.7±0.8(maximum ﬂux value reached after the release of the cuff), the area
under the curve (describing the increase and decrease of hyperaemic
ﬂow), and the time to recovery of the ﬂux (return to rest value). These
parameters were automatically calculated by the dedicated software of
laser-Doppler.Wealso calculatedmicrocirculatory resistance as the ratio
betweenmean arterial pressure (diastolic pressure plus 1/3 of the pulse
pressure) and laser-Doppler rest ﬂow for each step of the protocol
(Table 2). Traces of laser-Doppler were evaluated by operator unaware
of the subject identity and study phase.
Evaluation of the ﬂow at the armwas performed by means of strain
gauge plethysmography (Periquant 3800, GutmannMedizinelektronik,
Eurasburg, Germany) at rest and during reactive hyperaemia. We also
calculated forearm resistance as the ratio of mean pressure and forearm
blood ﬂow, at each step of the protocol. Plethysmographic traces were
evaluated by an operator unaware of the subject identity and study
phase [27].
Pressure and heart rate monitoring was donewith an oscillometric
device (Dinamap 845 XT, Critikon, Johnson and Johnson, Tampa, FL,
USA).
Blood glucose valueswere determined in the capillary bloodwith a
stick (Glucocard Memory 2, Arkray Inc Shia Japan), insulin values
were determined with Insulin DPC, Immulite.
3.3. Statistical analysis
The data is expressed as mean±SD and the statistical analysis was
carried out using two tailed analysis of variance (ANOVA; SPSS, SPSS
Italia srl, Italy) followed by post-hoc Student's t test for paired and
unpaired data, Bonferroni's correction was applied. Values of pb0.05
were considered to be signiﬁcant.
All patients gave their informed consent to the participation in the
study.
4. Results
Blood pressure, heart rate values never changed throughout the
study.
Blood glucose 2 hours after the load was 94±15 mg/dl, insulin
34.3±7.4 pmol/l.
Forearm blood ﬂow increased after ascorbic acid treatment—after
glucose load; while cutaneous microcirculation was unaffected by this
treatment (Table 4).
Forearm resistance decreased in the group treated with ascorbic
acid after oral glucose load (Table 4); microcirculatory resistance did
not change throughout the protocol (Table 4).
Oral glucose load determined a signiﬁcant reduction in post-
ischemic microcirculatory hyperaemia, at the beginning of the study
and after 10 days of treatment with ascorbic acid: hyperaemia was
studied at the peak ﬂow (Table 2) and calculated as area under the
curve (Fig. 1). The analysis of recovery time at laser Doppler during
reactive hyperaemia demonstrated a reduction after glucose load and
a recovery after treatment with ascorbic acid (Fig. 2). No differences
were relieved after placebo.
Glucose load reduced the response to acetylcholine administra-
tion; after 10 days of ascorbic acid and post-glucose load, the dose–line).
After vit C After placebo
Rest Glucose Rest Glucose
120±8 110±7 120±5 109±5
81±7 74±6 79±6 81±8
73±6 66±5 74±8 72±9
32.3±2.1 23.2±1.9* 33.1±1.4 33.4±1.9
1.8±0.5 1.7±0.6 1.6±0.8 1.7±0.8
Table 3
% increase in ﬂux with laser Doppler and plethysmography after ischemia and absolute values at rest (mean±SD).
% increase during reactive hyperemia Baseline Ascorbic Placebo
Rest Glucose Rest Glucose Rest Glucose
Laser Doppler 117.3±9 35.9±8* 131.5±12 65.5±8 # 120.1±10 33.8±9*
SG Pletysmography 285.7±23 182.6±13* 391.4±19 275.8±14 # 279.8±26 189.7±16*
*pb0.05 vs rest; #pb0.05 vs after-glucose/baseline.
Absolute values at rest Baseline Ascorbic Placebo
Rest Glucose Rest Glucose Rest Glucose
Laser Doppler (PU) 52.6±9.2 49.9±8.3 48.5±12.1 50.5±8.4 54.8±10.1 51.7±11.4
SG pletysmography (ml/100 ml min−1) 2.7±0.3 2.6±0.3 3.1±03 3.7±0.6* 2.8±0.2 2.7±0.4
*pb0.05 vs correspondent baseline.
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values with the higher stimulus (Table 4). Nitroprusside response
curve was unvaried throughout the study (Table 4).
A reduction in peak ﬂow after ischemia was also detected with
plethysmography after glucose, a recovery was observed after
ascorbic acid treatment, rest ﬂow was unchanged throughout the
study (Table 3). Placebo did not cause any change.10000
12000
PU x sec5. Discussion
The results show that oral glucose load in healthy subjects impairs
hyperaemic response at forearm and reduces endothelium dependent
vasodilation at cutaneous microcirculation; oral ascorbic acid can
recover these modiﬁcations. Forearm resistance decreased after
ascorbic acid treatment and after glucose load.
The increase of forearm ﬂow after vitamin C treatment and after
glucose may be attributed to a synergic action by insulin vasodilata-
tory properties and antioxidant improvement in these subjects. We
can hypothesise that insulin dependent vasodilation at baseline or
after placebo can be counteracted by increased oxidative stress due to
increased glucose concentration, with balance in circulatory regula-
tion. The administration of ascorbic acid can contrast the oxidative
stress, with enhanced effects of insulin on middle and small calibre
arteries.
No effects are detected in cutaneous microcirculation at rest,
vasoregulation in this district may be affected also by autonomic
balance; hyperinsulinemia may cause vagal withdrawal that canmask
the vasodilation effects of metabolic activation induced by hypergly-
cemia and glucose storage.
Some authors observed impairment of endothelial dependent
vasodilation at brachial artery after glucose administration [21,22],Table 4
% Increase in laser Doppler ﬂux with administration of acetylcholine and nitroprusside
(mean±SD).
Acetylcholine 0.10 mA 10 s 20 s 40 s
Baseline Rest 65.4±14 194.2±18 378.2±25
After glucose 35.4±11* 123.4±14* 260.8±21*
Ascorbic Rest 79.4±20 215.7±21 445.7±35
after glucose 31.8±10* 101.9±19* 345.3±21 #
Placebo Rest 63.4±13 200.2±18 381.2±24
After glucose 36.8±15* 128.4±13* 245.7±20*
*pb0.05 vs rest; #pb0.05 vs after-glucose/ascorbic.
Nitroprusside—0.10 mA 10 s 20 s 40 s
Baseline rest 69.5±12 211.2±19 399.2±24
after glucose 67.8±11 209.3±22 388.8±28
Ascorbic rest 70.1±18 215.7±25 397.7±35
after glucose 69.8±15 208.9±28 397.9±29
Placebo rest 66.5±13 215.1±21 388.4±25
after glucose 68.6±14 211.5±25 376.9±27other authors have studied microcirculation focusing mainly on
acetylcholine stimuli during hyperglycaemia [9]. Some other authors,
on the contrary, have shown a lack of effect of oral glucose on
endothelial function at brachial artery [23], this fact was highlighted
in young subjects with prevalence of female. In our experimental
setting, ischemia is generated by cuff inﬂation above the site of vessel
measurements in contrast to studies of vasodilation of the brachial
artery. Hence, ischemic metabolites could theoretically inﬂuence our
results and contribute to differences between our results and results
of studies performed on the brachial artery. We documented a
reduction in endothelium dependent vasodilation in microcirculation
after administering of glucose, these ﬁndings show that the response
to glucose can impair endothelial function in microcirculation, this
phenomenon can be attributed to oxidative stress induced by glucose
metabolism [8] and, probably, to the increase in insulin output, as
documented in studies on large arteries [17]. Beckman observed an
impairment in endothelium dependent vasodilation during hypergly-
caemia, prevented by ascorbate administration; the study was
performed with infusive technique so through an invasive approach
[16]. Prostaglandins, catabolites, nerves activity and nitric oxide
determine vasodilation during and after ischemic stimulus [18–20];
another mechanism of increased ﬂow in the ischemic area is the
dilation of middle calibre arteries (e.g. humeral artery), through an
endothelial dependent dilation. Glucose impairs hyperemia in our
work, both in peak ﬂow and in duration-amplitude of the phenom-
enon. A lack in the release or action of prostaglandins [24] and0
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Fig. 1. Area under the hyperemic curve at laser Doppler. *pb0.05 vs rest-baseline.
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Fig. 2. Recovery time of hyperemic curve. *pb0.05 vs rest-baseline.
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ﬂow. Nitric oxide system impairment can be evoked in the reduction of
duration-amplitude of hyperaemic curve, since nitric oxide plays a role
in determining the last part of hyperaemic curve, in prolonging the
increasedﬂow supply through aﬂuxmediated dilation [24,25]. Ascorbic
acid can recover these alterations, sowe can infer that oxidative stress is
involved and that it acts not only at endothelium level but also in the
complexity of circulatory regulation. In fact, hyperaemia is a crucial test,
showing how vasoregulation systems can respond to maximal request
of oxygen and metabolites from peripheral tissues.
Furthermore, ischemic conditions create a reductive stress [26], this
is followedby reperfusionwhichproduces a condition of oxidative stress
(ischemia–reperfusiondamage); this last aspect is probably ampliﬁedby
oxidative stress due to hyperglycemia and glucosemetabolism. Ascorbic
acid counteracts these phenomena, by improving the redox state. As a
consequence hyperaemic curve is restored after vitamin C. The curve is,
in fact, recovered in peak ﬂow (mainly prostaglandins mediation), in
amplitude (neurogenic andmyogenic response), and in total time (nitric
oxide contribution for ﬂow mediated dilation). Antioxidant acts on
multiple stages in vasoregulation, and preserves hyperaemic response;
some consequences, speculative and therapeutical, may be traced in
clinical conditions that determine an oxidative–reductive stress, in
particular for diabetic patients affected with atherosclerosis. Large
studies on antioxidant supplementation in this setting have been
deluding, but at least on speculative basis we can imagine a positive
role in particular dynamic conditions with higher oxidative stress, such
as strenuous exercise in patients with peripheral atherosclerosis and in
anaerobic phases of training in rehabilitation programmes; in fact these
conditions may elicit an ischemia–reperfusion phenomenon with
increasing oxidation.
Our study demonstrates that oral glucose load can cause endothelial
microcirculatory impairment as well as a reduction of hyperaemia in
macro a microcirculatory circulation. This is due to oxidative–reductive
stress asdemonstrated by the recoveryof thesephenomenaobtainedby
administering ascorbic acid.Conﬂict of interest statement
The authors state that they have no conﬂicts of interest.Learning points
• Oral glucose load can cause endothelial microcirculatory impair-
ment an macro a microcirculatory reduction of hyperemia.
• This is due to oxidative–reductive stress.
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